{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T05:06:32Z","timestamp":1779944792147,"version":"3.53.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004257","name":"Helse Vest","doi-asserted-by":"publisher","award":["F-13109"],"award-info":[{"award-number":["F-13109"]}],"id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004460","name":"Rotary Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004460","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains associated with significant morbidity and mortality, with acute graft-versus-host disease (aGVHD) being one of the leading contributors. Early prediction of aGVHD is essential for timely intervention, however, current diagnostic tools only detect disease after tissue damage has occurred. Circulating microRNAs (miRNAs) are potential non-invasive biomarkers for early detection or prediction of aGVHD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The objective of this study was to evaluate whether serum miRNA expression profiles obtained prior to transplantation can serve as a predictive tool for aGVHD in allo-HSCT recipients, with a focus on identifying signatures that support early detection and targeted management of post-transplant complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We investigated the association with serum miRNA profiles and the development of early complications in 78 allo-HSCT recipients. Serum samples were collected prior to transplantation, and miRNA expression was quantified using next-generation sequencing. Statistical and bioinformatic analyses were applied to identify miRNAs associated with aGVHD (grade II\u2013IV). Associations with the Endothelial Activation and Stress Index (EASIX) were also explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 78 allo-HSCT recipients, 18 patients (23%) developed aGVHD grade II\u2013IV. Early mortality occurred in nine patients within four months post-transplantation, and seven patients relapsed within one year post-transplantation. Receiver operating characteristic (ROC) analysis identified eight pretransplant miRNAs (miR-664a-5p, miR-20b-5p, miR-93-5p, miR-25-3p, miR-1224-5p, miR-106b-5p, miR-454-3p, and miR-3679-5p) associated with subsequent aGVHD development. A predictive model based on these miRNAs achieved an AUC of 0.855, which decreased to 0.692 after bootstrap validation. Hierarchical clustering using these miRNAs separated patients into two distinct clusters with markedly different aGVHD risks: cluster 1 showed a significantly higher incidence (42% vs. 9%) and greater severity, including all grade IV cases and most miRNAs were upregulated in patients developing aGVHD. Additionally, eight other miRNAs correlated with the EASIX score, reflecting endothelial stress, although these did not overlap with aGVHD-associated miRNAs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Pre-transplant serum miRNA signatures can predict aGVHD risk and severity, offering a novel approach for early patient stratification. These findings support the integration of miRNA profiling into pre-transplant assessment to guide personalized GVHD prophylaxis and monitoring. Further validation in independent cohorts is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1800792","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:51:08Z","timestamp":1779943868000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pre-transplant microRNA serum profiles and association with acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation"],"prefix":"10.3389","volume":"17","author":[{"given":"Guido","family":"Smits","sequence":"first","affiliation":[{"name":"K.G. Jebsen Center for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen","place":["Bergen, Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silje","family":"Johansen","sequence":"additional","affiliation":[{"name":"K.G. Jebsen Center for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen","place":["Bergen, Norway"]},{"name":"Department of Medicine, Haraldsplass Deaconess Hospital","place":["Bergen, Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin Paulsen","family":"Rye","sequence":"additional","affiliation":[{"name":"K.G. Jebsen Center for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen","place":["Bergen, Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley Joanne","family":"Hatfield","sequence":"additional","affiliation":[{"name":"Department of Immunology and Transfusion Medicine, Haukeland University Hospital","place":["Bergen, Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"G\u00f6rtler","sequence":"additional","affiliation":[{"name":"Department of Clinical Science, University of Bergen","place":["Bergen, Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guro Kristin","family":"Melve","sequence":"additional","affiliation":[{"name":"Department of Immunology and Transfusion Medicine, Haukeland University Hospital","place":["Bergen, Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kon","family":"Reikvam","sequence":"additional","affiliation":[{"name":"K.G. Jebsen Center for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen","place":["Bergen, Norway"]},{"name":"Department of Medicine, Haukeland University Hospital","place":["Bergen, Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-024-02248-9","article-title":"Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT","volume":"59","author":"Passweg","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"B2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","article-title":"Acute graft-versus-host disease","volume":"9","author":"Malard","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00342-3","article-title":"Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological Malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"11","author":"Penack","year":"2024","journal-title":"Lancet Haematol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2024.2441246","article-title":"Future biomarkers for acute graft-versus-host disease: potential roles of nucleic acids, metabolites, and immune cell markers","volume":"21","author":"Reikvam","year":"2025","journal-title":"Expert Rev Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092658","article-title":"Clinical significance of microRNAs in hematologic Malignancies and hematopoietic stem cell transplantation","volume":"15","author":"Sevcikova","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/genes14091796","article-title":"The role of microRNA in graft-versus-host-disease: a review","volume":"14","author":"Pitea","year":"2023","journal-title":"Genes (Basel)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005930","article-title":"MicroRNA serum profiles and chronic graft-versus-host disease","volume":"6","author":"Reikvam","year":"2022","journal-title":"Blood Adv"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-510586","article-title":"Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease","volume":"122","author":"Xiao","year":"2013","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01485","article-title":"Differential microRNA expression levels in cutaneous acute graft-versus-host disease","volume":"9","author":"Atarod","year":"2018","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30108-4","article-title":"EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis","volume":"4","author":"Luft","year":"2017","journal-title":"Lancet Haematol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multi-center standardization of acute graft-versus-host disease clinical data collection: a report from the MAGIC consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B12","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41409-023-01922-8","article-title":"EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation","volume":"58","author":"Sanchez-Escamilla","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010570","article-title":"CRISPR\/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model","volume":"8","author":"Neidemire-Colley","year":"2024","journal-title":"Blood Adv"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.137","article-title":"MicroRNA-146a reduces MHC-II expression via targeting JAK\/STAT signaling in dendritic cells after stem cell transplantation","volume":"31","author":"Stickel","year":"2017","journal-title":"Leukemia"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-617258","article-title":"MicroRNA-155-deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation","volume":"126","author":"Chen","year":"2015","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00056","article-title":"miR-146a and miR-155 expression levels in acute graft-versus-host disease incidence","volume":"7","author":"Atarod","year":"2016","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-025-02583-5","article-title":"Pre-transplant inflammation and its associations with acute GvHD and mortality in pediatric allogeneic hematopoietic stem cell transplantation patients","volume":"60","author":"Verbeek","year":"2025","journal-title":"Bone Marrow Transplant"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.145847","article-title":"The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes","volume":"101","author":"Artz","year":"2016","journal-title":"Haematologica"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26125744","article-title":"Ferritin in acute myeloid leukemia: not only a marker of inflammation and iron overload, but also a regulator of cellular iron metabolism, signaling and communication","volume":"26","author":"Reikvam","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/ajh.24136","article-title":"MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-\u03b3 production","volume":"90","author":"Sang","year":"2015","journal-title":"Am J Hematol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2023000425","article-title":"Planning GvHD preemptive therapy: risk factors, biomarkers, and prognostic scores","volume":"2023","author":"Rozmus","year":"2023","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01771","article-title":"Optimizing donor choice and GVHD prophylaxis in allogeneic hematopoietic cell transplantation","volume":"39","author":"Holtan","year":"2021","journal-title":"J Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1379643","article-title":"The three paralogous microRNA clusters in development and disease, miR-17-92, miR-106a-363, and miR-106b-25","volume":"2016","author":"Khuu","year":"2016","journal-title":"Scientifica (Cairo)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3892\/etm.2021.9754","article-title":"miR-454-3p prevents ox-LDL-induced apoptosis in HAECs by targeting TRPC3","volume":"21","author":"Liao","year":"2021","journal-title":"Exp Ther Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103834","article-title":"miR-25-3p promotes endothelial cell angiogenesis in aging mice via TULA-2\/SYK\/VEGFR-2 downregulation","volume":"12","author":"Lian","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14482","article-title":"A guide to miRNAs in inflammation and innate immune responses","volume":"285","author":"Nejad","year":"2018","journal-title":"FEBS J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/bjh.20210","article-title":"EASIX score predicts non-relapse mortality and severe infection in elderly patients undergoing allo-HSCT","volume":"207","author":"Liu","year":"2025","journal-title":"Br J Haematol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11906-016-0696-8","article-title":"Role of microRNA in endothelial dysfunction and hypertension","volume":"18","author":"Nemecz","year":"2016","journal-title":"Curr Hypertens Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2013_056","article-title":"Expression and prognostic significance of hsa-miR-142-3p in acute leukemias","volume":"60","author":"Dahlhaus","year":"2013","journal-title":"Neoplasma"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-019-0240-y","article-title":"Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer","volume":"8","author":"Chirshev","year":"2019","journal-title":"Clin Transl Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.253716","article-title":"Endothelial damage and dysfunction in acute graft-versus-host disease","volume":"106","author":"Cordes","year":"2021","journal-title":"Haematologica"},{"key":"B32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jtct.2021.11.004","article-title":"Association of CD34 cell dose with 5-year overall survival after peripheral blood allogeneic hematopoietic cell transplantation in adults with hematologic Malignancies","volume":"28","author":"Gauntner","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00845","article-title":"Peripheral blood stem cell mobilization in healthy donors by granulocyte colony-stimulating factor causes preferential mobilization of lymphocyte subsets","volume":"9","author":"Melve","year":"2018","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2026.102099","article-title":"Endothelial activation and stress index (EASIX) score is a stronger predictor of survival after allogeneic hematopoietic stem cell transplantation than acute-phase biomarkers","volume":"28","author":"Rolfsnes","year":"2026","journal-title":"Cytotherapy"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-403063","article-title":"Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study","volume":"119","author":"Levine","year":"2012","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2113476118","article-title":"Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation","volume":"119","author":"Cheng","year":"2022","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1800792\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:51:15Z","timestamp":1779943875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1800792\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2026.1800792"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1800792","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"article-number":"1800792"}}